English Overview
Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis
This Activity for
- Resident / Fellow
- Physician
- Pharmacy
- Clinical Pharmacy
What I will learn?
Communicate Baricitinib and Ixekizumab value proposition in a speaker program setting in order to communicate what the product may mean to people living with Rheumatoid Arthritis Psoriatic Arthritis and Ankylosing Spondylarthritis diseases
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis Certificate
Certificate |
Certificate | Free |
VAT 15% Included
